The medicine is injected into the eye and can be given safely in the office. Eye injections are a treatment, not a cure for this condition, and patients often need frequent injections to maintain ...

Sold as Susvimo, it's the first device that slowly releases ranibizumab, a medicine that treats eye diseases, so patients don’t need frequent injections. DME affects about 750,000 people in the ...

In the trial, people with diabetic macular edema who received Susvimo refilled every six months achieved noninferior improvements in vision compared with those receiving monthly 0.5-mg ranibizumab ...

In Josh Ruben’s “Heart Eyes,” Ally (Olivia Holt) works in advertising for a high-end jewelry brand. Her latest campaign pitch on doomed lovers (Romeo and Juliet, Bonnie and Clyde, Jack and Rose, etc.) ...

Refreshingly, “Heart Eyes,” directed by Josh Ruben, is a flip throwback to a time when killers were creeps and victims were chum. A Valentine’s Day massacre in which PDA leads to public ...

The nod is the second indication for Susvimo, an alternative to regular eye injections that was originally approved to treat wet age-related macular degeneration in October 2021. Twelve months ...

Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with DME with fewer treatments than standard-of-care eye injections. Susvimo is now available to U.S. retina ...

Susvimo is the first FDA-approved treatment for DME that maintains vision with fewer treatments than standard injections. The refillable ocular implant delivers ranibizumab continuously, offering a ...

showing sustained vision improvements with fewer treatments than standard eye injections. The FDA has approved Roche’s Susvimo (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant ...

Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME) – – With as few as two treatments per year, ...

Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with DME with fewer treatments than standard-of-care eye injections. Susvimo is now available to U.S. retina ...